Drospirenone And Ethinyl Estradiol Kit
Product Images NDC 79929-019

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Drospirenone And Ethinyl Estradiol (NDC 79929-019). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Naari Pte. Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Blister)

Drosperinone and Ethinyl Estradiol Tablets USP 3 mg/0.03 mg dosage form kit containing 28 tablets. The label includes a weekly pill schedule with circles arranged by days of the week in a 4-week layout. Manufacturer is Naari Pte. Limited. Storage instructions specify 25°C (77°F) with permitted excursions, and a caution to keep out of reach of children.*

FDA Label Image

Image Description (Chart)

An effectiveness chart illustrating pregnancy rates per 100 women per year relative to different contraceptive methods. It ranks methods from fewer pregnancies (implants, injections, intrauterine devices, sterilization) to more pregnancies (no birth control). Intermediate methods include birth control pills, skin patches, vaginal rings with hormones, condoms, diaphragms, and behavioral methods like abstinence during fertile days, spermicides, and withdrawal.*

FDA Label Image

Structure Formula (Description)

Chemical structure diagrams of the active ingredients Drospirenone and Ethinyl Estradiol. Each structure is presented as a detailed molecular diagram, labeled below with its respective ingredient name.*

FDA Label Image

Figure 1 (Figure 1)

A forest plot chart showing hazard ratios, rate ratios, and odds ratios from various studies grouped into prospective cohort studies, retrospective cohort studies, case-control studies, and non-fatal idiopathic cases only. The horizontal axis is logarithmic, ranging approximately from 0.1 to 10, with data points and confidence intervals for studies including Ingenix, EURAS, LASS, FDA-funded, Danish, MEGA, German case-control, PharMetrics, and GPRD studies.*

FDA Label Image

Figure 2 (Figure 2)

A horizontal bar chart comparing ranges of an unspecified variable across four groups: Non-Pregnant Non-COC users (range 1-5), COC users (range 3-9), Pregnancy (range 5-20), and Postpartum (12 weeks only) with a higher range from 40 to 65. The chart visually shows increasing values from Non-Pregnant Non-COC users up to Postpartum group.*

FDA Label Image

Image Description (Figure 3)

A forest plot depicting risk ratios with 95% confidence intervals from multiple cohort studies comparing Drospirenone and Ethinyl Estradiol use with a reference group. The vertical line at 1.0 indicates null effect, with points and error bars showing the estimated risk ratios and uncertainty ranges for each study.*

FDA Label Image

Image Description (No.of Women)

A horizontal bar chart illustrating the number of women with a blood clot out of 10,000 women years in different groups: Non-Pregnant Non-COC users, COC users, pregnant women, and postpartum women (12 weeks only). Each bar shows a range of values indicating blood clot risk across these groups.*

FDA Label Image

Outer Carton (Outer Carton)

Packaging label for Drospirenone and Ethinyl Estradiol Tablets USP 3 mg/0.03 mg kit, labeled by Naari Pte. Limited. The kit includes 3 pouches, each containing 1 blister card with 28 tablets. The label states it is a prescription drug intended to prevent pregnancy, with warnings about its limitations regarding HIV and other sexually transmitted diseases. The label also includes storage instructions and manufacturer details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.